HomepageEarnings Events Newsdesk 3 weeks ago ESAB Corp (ESAB) ESAB Corporation Announces CFO Transition ESAB Corp (NYSE: ESAB) FY 2026 Management Update Merck & Co., Inc. (MRK) European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens » « Ares Management Corporation (ARES) Ares Raises Combined $5.4 Billion for U.S. and Europe Value-Add Real Estate Strategies Newsdesk:
